Some content of this application is unavailable at the moment.
If this situation persist, please contact us atFeedback&Contact
1. (WO2019027293) COMPOSITION FOR PREVENTING OR TREATING OBESITY COMPRISING ML323 AS ACTIVE INGREDIENT
Latest bibliographic data on file with the International Bureau    Submit observation

Pub. No.: WO/2019/027293 International Application No.: PCT/KR2018/008862
Publication Date: 07.02.2019 International Filing Date: 03.08.2018
IPC:
A61K 31/506 (2006.01) ,A23L 33/10 (2016.01)
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
K
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31
Medicinal preparations containing organic active ingredients
33
Heterocyclic compounds
395
having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
495
having six-membered rings with two nitrogen atoms as the only ring hetero atoms, e.g. piperazine
505
Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
506
not condensed and containing further heterocyclic rings
[IPC code unknown for A23L 33/10]
Applicants:
연세대학교 산학협력단 INDUSTRY-ACADEMIC COOPERATION FOUNDATION, YONSEI UNIVERSITY [KR/KR]; 서울시 서대문구 연세로 50 50, Yonsei-ro Seodaemun-gu Seoul 03722, KR
Inventors:
전경희 CHUN, Kyung Hee; KR
이진아 LEE, Jin Ah; KR
백정환 BAEK, Jung Hwan; KR
김남준 KIM, Nam Jun; KR
Agent:
특허법인 이룸리온 ERUUM & LEEON INTELLECTUAL PROPERTY LAW FIRM; 서울시 서초구 사평대로 108, 3층 (반포동) (Banpo-dong) 3rd Floor, 108, Sapyeong-daero, Seocho-gu Seoul 06575, KR
Priority Data:
10-2017-009898004.08.2017KR
Title (EN) COMPOSITION FOR PREVENTING OR TREATING OBESITY COMPRISING ML323 AS ACTIVE INGREDIENT
(FR) COMPOSITION POUR LA PRÉVENTION OU LE TRAITEMENT DE L'OBÉSITÉ COMPRENANT LE ML323 UTILISÉ COMME PRINCIPE ACTIF
(KO) ML323을 유효성분으로 포함하는 비만 예방 또는 치료용 조성물
Abstract:
(EN) The present invention relates to a pharmaceutical composition for preventing or treating obesity comprising ML323 or a salt thereof as an active ingredient; and a functional health food composition for preventing or improving obesity.
(FR) La présente invention concerne une composition pharmaceutique pour la prévention ou le traitement de l'obésité comprenant le ML323, ou un sel de celui-ci, utilisé comme principe actif ; et une composition alimentaire naturelle fonctionnelle pour la prévention ou l'atténuation de l'obésité.
(KO) 본 발명은 ML323 또는 이의 염을 유효성분으로 포함하는 비만 예방 또는 치료용 약학적 조성물; 및 비만 예방 또는 개선용 건강기능성 식품 조성물에 관한 것이다.
front page image
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DJ, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IR, IS, JO, JP, KE, KG, KH, KN, KP, KW, KZ, LA, LC, LK, LR, LS, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SA, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW
African Regional Intellectual Property Organization (ARIPO) (BW, GH, GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, ST, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Office (AM, AZ, BY, KG, KZ, RU, TJ, TM)
European Patent Office (EPO) (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, KM, ML, MR, NE, SN, TD, TG)
Publication Language: Korean (KO)
Filing Language: Korean (KO)